| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocardial Infarction | 64 | 2024 | 1031 | 4.740 |
Why?
|
| Hypertension | 41 | 2021 | 1236 | 4.250 |
Why?
|
| Cardiopulmonary Resuscitation | 14 | 2020 | 258 | 2.800 |
Why?
|
| Antihypertensive Agents | 22 | 2021 | 487 | 2.380 |
Why?
|
| Emergency Service, Hospital | 37 | 2020 | 1977 | 2.330 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 8 | 2020 | 84 | 2.320 |
Why?
|
| Blood Pressure | 24 | 2020 | 1743 | 2.180 |
Why?
|
| Ticlopidine | 8 | 2014 | 55 | 1.970 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 8 | 2015 | 86 | 1.740 |
Why?
|
| Angioplasty, Balloon, Coronary | 19 | 2014 | 152 | 1.690 |
Why?
|
| Heart Failure | 31 | 2024 | 2142 | 1.670 |
Why?
|
| American Heart Association | 17 | 2020 | 311 | 1.550 |
Why?
|
| Cardiology Service, Hospital | 7 | 2020 | 27 | 1.470 |
Why?
|
| Cardiology | 9 | 2020 | 281 | 1.450 |
Why?
|
| Quality of Health Care | 19 | 2024 | 610 | 1.400 |
Why?
|
| Aged | 143 | 2025 | 22035 | 1.390 |
Why?
|
| Asthma | 15 | 2016 | 2258 | 1.360 |
Why?
|
| Exercise Test | 13 | 2021 | 619 | 1.340 |
Why?
|
| Risk Assessment | 25 | 2023 | 3286 | 1.340 |
Why?
|
| Male | 218 | 2025 | 63146 | 1.300 |
Why?
|
| Stroke | 14 | 2023 | 1111 | 1.290 |
Why?
|
| Female | 223 | 2025 | 68162 | 1.270 |
Why?
|
| Humans | 328 | 2025 | 128896 | 1.270 |
Why?
|
| Medicare | 10 | 2024 | 734 | 1.210 |
Why?
|
| Vascular Surgical Procedures | 3 | 2015 | 295 | 1.190 |
Why?
|
| Tomography, X-Ray Computed | 52 | 1995 | 2530 | 1.190 |
Why?
|
| United States | 92 | 2024 | 13975 | 1.150 |
Why?
|
| Middle Aged | 150 | 2025 | 30977 | 1.150 |
Why?
|
| Health Expenditures | 5 | 2023 | 187 | 1.140 |
Why?
|
| Lower Extremity | 3 | 2015 | 404 | 1.110 |
Why?
|
| Medication Adherence | 13 | 2025 | 571 | 1.110 |
Why?
|
| Defibrillators, Implantable | 11 | 2021 | 295 | 1.100 |
Why?
|
| Heart Arrest | 6 | 2020 | 327 | 1.090 |
Why?
|
| Sex Factors | 16 | 2017 | 1947 | 1.080 |
Why?
|
| Platelet Aggregation Inhibitors | 7 | 2014 | 453 | 1.080 |
Why?
|
| Cardiovascular Diseases | 12 | 2025 | 2013 | 1.070 |
Why?
|
| Guideline Adherence | 12 | 2015 | 526 | 1.040 |
Why?
|
| Emergency Medicine | 7 | 2012 | 228 | 1.010 |
Why?
|
| Medication Errors | 5 | 2011 | 96 | 0.990 |
Why?
|
| Hospitalization | 28 | 2024 | 2080 | 0.970 |
Why?
|
| Coronary Disease | 10 | 2011 | 389 | 0.960 |
Why?
|
| Stroke Volume | 15 | 2020 | 587 | 0.950 |
Why?
|
| Coronary Artery Disease | 9 | 2021 | 695 | 0.920 |
Why?
|
| Peripheral Arterial Disease | 3 | 2015 | 458 | 0.920 |
Why?
|
| Myocardial Reperfusion | 12 | 2010 | 52 | 0.910 |
Why?
|
| Medical Order Entry Systems | 3 | 2011 | 44 | 0.900 |
Why?
|
| Retrospective Studies | 76 | 2023 | 14546 | 0.890 |
Why?
|
| Risk Factors | 55 | 2021 | 9792 | 0.880 |
Why?
|
| Aged, 80 and over | 49 | 2024 | 7050 | 0.870 |
Why?
|
| Adrenergic beta-Antagonists | 13 | 2017 | 320 | 0.870 |
Why?
|
| Patient Compliance | 14 | 2014 | 563 | 0.860 |
Why?
|
| Pharmacists | 5 | 2013 | 259 | 0.830 |
Why?
|
| Thrombolytic Therapy | 10 | 2008 | 137 | 0.830 |
Why?
|
| Reminder Systems | 6 | 2025 | 173 | 0.820 |
Why?
|
| Proportional Hazards Models | 16 | 2017 | 1221 | 0.800 |
Why?
|
| Time Factors | 48 | 2020 | 6568 | 0.800 |
Why?
|
| Colorado | 38 | 2017 | 4443 | 0.790 |
Why?
|
| Ambulatory Care | 6 | 2012 | 509 | 0.780 |
Why?
|
| Primary Prevention | 8 | 2019 | 191 | 0.770 |
Why?
|
| Registries | 27 | 2017 | 1916 | 0.770 |
Why?
|
| Health Services | 2 | 2016 | 106 | 0.750 |
Why?
|
| Hospitals | 11 | 2024 | 628 | 0.740 |
Why?
|
| Death, Sudden, Cardiac | 7 | 2019 | 179 | 0.740 |
Why?
|
| Drug Prescriptions | 5 | 2011 | 253 | 0.730 |
Why?
|
| Electronic Health Records | 6 | 2017 | 966 | 0.730 |
Why?
|
| Practice Patterns, Physicians' | 9 | 2020 | 1281 | 0.730 |
Why?
|
| Outpatients | 4 | 2017 | 366 | 0.720 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 8 | 2017 | 207 | 0.720 |
Why?
|
| Coronary Artery Bypass | 6 | 2021 | 224 | 0.710 |
Why?
|
| Quality of Life | 14 | 2016 | 2706 | 0.690 |
Why?
|
| Follow-Up Studies | 28 | 2021 | 4917 | 0.690 |
Why?
|
| Fee-for-Service Plans | 4 | 2023 | 88 | 0.670 |
Why?
|
| Drug Monitoring | 5 | 2009 | 193 | 0.650 |
Why?
|
| Telemedicine | 5 | 2020 | 773 | 0.650 |
Why?
|
| Prosthesis Implantation | 3 | 2015 | 149 | 0.640 |
Why?
|
| Clinical Pharmacy Information Systems | 3 | 2007 | 6 | 0.640 |
Why?
|
| Cell Phone | 2 | 2021 | 69 | 0.630 |
Why?
|
| Practice Guidelines as Topic | 15 | 2020 | 1523 | 0.620 |
Why?
|
| Self Care | 4 | 2020 | 369 | 0.620 |
Why?
|
| Treatment Outcome | 43 | 2020 | 10239 | 0.610 |
Why?
|
| Fractures, Bone | 16 | 1995 | 416 | 0.610 |
Why?
|
| Incidence | 23 | 2017 | 2634 | 0.600 |
Why?
|
| Managed Care Programs | 8 | 2015 | 135 | 0.600 |
Why?
|
| Health Maintenance Organizations | 15 | 2013 | 98 | 0.600 |
Why?
|
| Coronary Angiography | 6 | 2018 | 341 | 0.600 |
Why?
|
| Primary Health Care | 8 | 2021 | 1661 | 0.590 |
Why?
|
| Adult | 92 | 2023 | 35361 | 0.580 |
Why?
|
| Heart Diseases | 7 | 2016 | 356 | 0.580 |
Why?
|
| Drug Therapy, Computer-Assisted | 2 | 2007 | 10 | 0.570 |
Why?
|
| Chest Pain | 3 | 2007 | 89 | 0.560 |
Why?
|
| Ventricular Dysfunction, Left | 6 | 2020 | 387 | 0.560 |
Why?
|
| Treatment Refusal | 6 | 2010 | 88 | 0.560 |
Why?
|
| Electrocardiography | 15 | 2011 | 602 | 0.560 |
Why?
|
| Prehypertension | 3 | 2014 | 27 | 0.550 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2024 | 764 | 0.550 |
Why?
|
| Hospital Mortality | 14 | 2024 | 853 | 0.530 |
Why?
|
| Percutaneous Coronary Intervention | 4 | 2021 | 475 | 0.530 |
Why?
|
| Population Surveillance | 2 | 2017 | 428 | 0.520 |
Why?
|
| Bone Neoplasms | 12 | 1999 | 227 | 0.520 |
Why?
|
| Health Care Reform | 2 | 2018 | 100 | 0.510 |
Why?
|
| Speech Recognition Software | 2 | 2015 | 11 | 0.510 |
Why?
|
| Fibrinolytic Agents | 7 | 2010 | 264 | 0.500 |
Why?
|
| Evidence-Based Medicine | 9 | 2020 | 729 | 0.500 |
Why?
|
| Comorbidity | 14 | 2018 | 1542 | 0.500 |
Why?
|
| Cohort Studies | 36 | 2024 | 5394 | 0.500 |
Why?
|
| Renal Insufficiency, Chronic | 6 | 2018 | 561 | 0.490 |
Why?
|
| Emergency Medical Services | 10 | 2020 | 562 | 0.490 |
Why?
|
| Health Resources | 1 | 2016 | 121 | 0.490 |
Why?
|
| Blood Pressure Determination | 8 | 2020 | 150 | 0.480 |
Why?
|
| Volunteers | 1 | 2015 | 32 | 0.480 |
Why?
|
| Ventricular Function, Left | 8 | 2018 | 526 | 0.480 |
Why?
|
| Health Services Research | 9 | 2013 | 392 | 0.480 |
Why?
|
| Consensus | 7 | 2020 | 644 | 0.470 |
Why?
|
| Internship and Residency | 4 | 2022 | 1052 | 0.470 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2015 | 861 | 0.470 |
Why?
|
| Multivariate Analysis | 21 | 2013 | 1504 | 0.460 |
Why?
|
| Intermittent Claudication | 1 | 2015 | 118 | 0.460 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 7 | 2021 | 421 | 0.450 |
Why?
|
| Drug-Eluting Stents | 5 | 2014 | 65 | 0.440 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 2 | 2010 | 9 | 0.440 |
Why?
|
| Myocardial Ischemia | 5 | 2007 | 254 | 0.430 |
Why?
|
| Case Management | 2 | 2013 | 64 | 0.430 |
Why?
|
| Mineralocorticoid Receptor Antagonists | 1 | 2013 | 46 | 0.430 |
Why?
|
| Hyperkalemia | 1 | 2013 | 27 | 0.430 |
Why?
|
| Quality Improvement | 2 | 2021 | 1101 | 0.430 |
Why?
|
| Observational Studies as Topic | 1 | 2014 | 108 | 0.430 |
Why?
|
| California | 7 | 2017 | 402 | 0.420 |
Why?
|
| Surveys and Questionnaires | 21 | 2016 | 5355 | 0.420 |
Why?
|
| Soft Tissue Neoplasms | 4 | 1997 | 111 | 0.420 |
Why?
|
| Diabetes Mellitus | 5 | 2013 | 991 | 0.420 |
Why?
|
| Prognosis | 18 | 2020 | 3787 | 0.410 |
Why?
|
| Osteomyelitis | 6 | 1999 | 122 | 0.410 |
Why?
|
| Delivery of Health Care, Integrated | 6 | 2020 | 248 | 0.410 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2016 | 359 | 0.410 |
Why?
|
| Community Pharmacy Services | 1 | 2013 | 47 | 0.400 |
Why?
|
| Health Status | 11 | 2013 | 750 | 0.400 |
Why?
|
| Age Factors | 14 | 2020 | 3133 | 0.400 |
Why?
|
| Glucocorticoids | 2 | 2015 | 570 | 0.400 |
Why?
|
| Diagnosis, Computer-Assisted | 2 | 2013 | 85 | 0.400 |
Why?
|
| Defibrillators | 1 | 2012 | 17 | 0.400 |
Why?
|
| Medicare Part C | 1 | 2013 | 41 | 0.400 |
Why?
|
| Chlamydia trachomatis | 3 | 2006 | 44 | 0.400 |
Why?
|
| Ischemia | 1 | 2015 | 396 | 0.390 |
Why?
|
| Emergencies | 6 | 2020 | 164 | 0.390 |
Why?
|
| Prospective Studies | 18 | 2016 | 7060 | 0.390 |
Why?
|
| Mass Screening | 4 | 2014 | 1121 | 0.390 |
Why?
|
| Cerebrovascular Disorders | 1 | 2012 | 91 | 0.380 |
Why?
|
| Survival Rate | 9 | 2017 | 1884 | 0.380 |
Why?
|
| Cardiovascular Agents | 2 | 2025 | 155 | 0.380 |
Why?
|
| Chlamydia Infections | 3 | 2006 | 71 | 0.370 |
Why?
|
| Data Interpretation, Statistical | 4 | 2016 | 336 | 0.370 |
Why?
|
| Muscular Diseases | 5 | 1993 | 110 | 0.370 |
Why?
|
| Electric Countershock | 3 | 2018 | 105 | 0.370 |
Why?
|
| Mortality | 5 | 2018 | 310 | 0.360 |
Why?
|
| Endovascular Procedures | 1 | 2015 | 304 | 0.360 |
Why?
|
| Renal Insufficiency | 2 | 2011 | 150 | 0.360 |
Why?
|
| Angina Pectoris | 4 | 2007 | 68 | 0.360 |
Why?
|
| Internet | 2 | 2013 | 616 | 0.360 |
Why?
|
| Text Messaging | 2 | 2025 | 146 | 0.360 |
Why?
|
| Physicians | 5 | 2024 | 846 | 0.360 |
Why?
|
| Health Promotion | 2 | 2014 | 712 | 0.360 |
Why?
|
| Advanced Cardiac Life Support | 5 | 2020 | 27 | 0.350 |
Why?
|
| Survival Analysis | 10 | 2013 | 1282 | 0.350 |
Why?
|
| Adolescent | 38 | 2021 | 20197 | 0.350 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2021 | 1264 | 0.350 |
Why?
|
| Cardiac Catheterization | 4 | 2019 | 583 | 0.350 |
Why?
|
| Cholesterol, LDL | 4 | 2021 | 360 | 0.350 |
Why?
|
| Delivery of Health Care | 4 | 2012 | 896 | 0.350 |
Why?
|
| Learning | 1 | 2014 | 381 | 0.350 |
Why?
|
| Body Mass Index | 10 | 2017 | 2244 | 0.350 |
Why?
|
| Patient Selection | 4 | 2013 | 671 | 0.340 |
Why?
|
| Multimorbidity | 3 | 2020 | 42 | 0.340 |
Why?
|
| Diabetic Angiopathies | 3 | 2015 | 263 | 0.340 |
Why?
|
| Healthcare Disparities | 4 | 2014 | 570 | 0.330 |
Why?
|
| Health Care Costs | 6 | 2019 | 404 | 0.330 |
Why?
|
| Time and Motion Studies | 3 | 2007 | 21 | 0.330 |
Why?
|
| Ankle Injuries | 5 | 1995 | 81 | 0.330 |
Why?
|
| Patient Satisfaction | 5 | 2013 | 639 | 0.320 |
Why?
|
| Logistic Models | 16 | 2012 | 1963 | 0.320 |
Why?
|
| Prescription Drugs | 1 | 2011 | 116 | 0.320 |
Why?
|
| Acute Coronary Syndrome | 2 | 2010 | 267 | 0.320 |
Why?
|
| Insurance, Health | 2 | 2021 | 269 | 0.320 |
Why?
|
| Metabolic Syndrome | 2 | 2009 | 339 | 0.320 |
Why?
|
| Postoperative Hemorrhage | 1 | 2010 | 85 | 0.320 |
Why?
|
| Exercise Tolerance | 2 | 2008 | 266 | 0.320 |
Why?
|
| Patient Preference | 1 | 2011 | 182 | 0.310 |
Why?
|
| Clinical Protocols | 1 | 2010 | 255 | 0.310 |
Why?
|
| Safety Management | 2 | 2007 | 116 | 0.310 |
Why?
|
| Chi-Square Distribution | 9 | 2013 | 513 | 0.310 |
Why?
|
| Image Processing, Computer-Assisted | 13 | 1991 | 739 | 0.310 |
Why?
|
| Arrhythmias, Cardiac | 3 | 2018 | 312 | 0.300 |
Why?
|
| Information Services | 1 | 2008 | 45 | 0.300 |
Why?
|
| Risk Management | 1 | 2008 | 92 | 0.290 |
Why?
|
| Obesity | 3 | 2017 | 2844 | 0.290 |
Why?
|
| Health Behavior | 3 | 2016 | 732 | 0.280 |
Why?
|
| Policy Making | 2 | 2008 | 89 | 0.280 |
Why?
|
| Sick Role | 2 | 2006 | 17 | 0.280 |
Why?
|
| Heart Function Tests | 2 | 2019 | 61 | 0.280 |
Why?
|
| Acetabulum | 7 | 1992 | 103 | 0.280 |
Why?
|
| Telephone | 4 | 2015 | 167 | 0.270 |
Why?
|
| Angina, Unstable | 6 | 2009 | 77 | 0.270 |
Why?
|
| Research Report | 3 | 2016 | 76 | 0.270 |
Why?
|
| Minnesota | 5 | 2017 | 145 | 0.270 |
Why?
|
| Child, Preschool | 21 | 2017 | 10457 | 0.270 |
Why?
|
| Organizational Policy | 1 | 2007 | 76 | 0.270 |
Why?
|
| Quality Assurance, Health Care | 5 | 2010 | 319 | 0.270 |
Why?
|
| Clinical Trials as Topic | 6 | 2009 | 1002 | 0.270 |
Why?
|
| Research Design | 8 | 2012 | 1038 | 0.270 |
Why?
|
| Dyslipidemias | 3 | 2014 | 176 | 0.260 |
Why?
|
| Hemorrhage | 4 | 2016 | 658 | 0.260 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 2 | 2019 | 11 | 0.260 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2005 | 225 | 0.260 |
Why?
|
| Laboratories, Hospital | 1 | 2006 | 14 | 0.260 |
Why?
|
| Residence Characteristics | 3 | 2014 | 326 | 0.260 |
Why?
|
| Crime Victims | 2 | 2008 | 105 | 0.260 |
Why?
|
| Radiography | 11 | 2000 | 863 | 0.260 |
Why?
|
| Patient Discharge | 7 | 2023 | 858 | 0.260 |
Why?
|
| Anticoagulants | 2 | 2014 | 622 | 0.260 |
Why?
|
| Acute Kidney Injury | 1 | 2013 | 786 | 0.250 |
Why?
|
| Patient Participation | 3 | 2020 | 402 | 0.250 |
Why?
|
| Age Distribution | 6 | 2013 | 376 | 0.250 |
Why?
|
| Physician's Role | 1 | 2007 | 202 | 0.250 |
Why?
|
| Warfarin | 2 | 2008 | 150 | 0.250 |
Why?
|
| International Normalized Ratio | 1 | 2005 | 47 | 0.250 |
Why?
|
| Sexually Transmitted Diseases | 2 | 2008 | 146 | 0.240 |
Why?
|
| Preventive Health Services | 2 | 2007 | 143 | 0.240 |
Why?
|
| Biomedical Research | 2 | 2008 | 654 | 0.240 |
Why?
|
| Malpractice | 2 | 2023 | 37 | 0.240 |
Why?
|
| Insurance Claim Review | 2 | 2016 | 74 | 0.240 |
Why?
|
| Myocardial Revascularization | 3 | 2018 | 70 | 0.240 |
Why?
|
| Cross-Sectional Studies | 18 | 2016 | 5032 | 0.240 |
Why?
|
| Diffusion of Innovation | 1 | 2005 | 95 | 0.230 |
Why?
|
| Cost-Benefit Analysis | 7 | 2014 | 615 | 0.230 |
Why?
|
| Randomized Controlled Trials as Topic | 8 | 2021 | 1366 | 0.230 |
Why?
|
| Postoperative Complications | 4 | 2015 | 2494 | 0.230 |
Why?
|
| Cardiologists | 1 | 2024 | 46 | 0.230 |
Why?
|
| Quality Indicators, Health Care | 5 | 2012 | 299 | 0.230 |
Why?
|
| Data Collection | 7 | 2008 | 652 | 0.230 |
Why?
|
| Child | 24 | 2017 | 20824 | 0.230 |
Why?
|
| Health Facility Planning | 1 | 2003 | 1 | 0.220 |
Why?
|
| Socioeconomic Factors | 8 | 2016 | 1192 | 0.220 |
Why?
|
| Community-Based Participatory Research | 3 | 2014 | 145 | 0.220 |
Why?
|
| Predictive Value of Tests | 9 | 2020 | 1967 | 0.210 |
Why?
|
| Friends | 1 | 2004 | 51 | 0.210 |
Why?
|
| Models, Cardiovascular | 2 | 2023 | 193 | 0.210 |
Why?
|
| Rape | 1 | 2004 | 38 | 0.210 |
Why?
|
| Odds Ratio | 9 | 2014 | 1019 | 0.210 |
Why?
|
| Hip Prosthesis | 4 | 1992 | 34 | 0.210 |
Why?
|
| Health Services Needs and Demand | 2 | 2009 | 258 | 0.210 |
Why?
|
| Ticks | 2 | 1993 | 19 | 0.210 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2016 | 525 | 0.200 |
Why?
|
| Anti-Bacterial Agents | 4 | 2003 | 1701 | 0.200 |
Why?
|
| Hand | 2 | 1997 | 150 | 0.200 |
Why?
|
| Joint Dislocations | 3 | 2012 | 64 | 0.200 |
Why?
|
| Bites and Stings | 2 | 1993 | 32 | 0.200 |
Why?
|
| Anti-Infective Agents | 1 | 2005 | 246 | 0.200 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2018 | 2421 | 0.200 |
Why?
|
| Patient Readmission | 5 | 2016 | 674 | 0.200 |
Why?
|
| Reproducibility of Results | 9 | 2021 | 3042 | 0.200 |
Why?
|
| Lyme Disease | 2 | 1993 | 53 | 0.200 |
Why?
|
| Pharmaceutical Preparations | 1 | 2004 | 171 | 0.190 |
Why?
|
| Prevalence | 12 | 2014 | 2540 | 0.190 |
Why?
|
| Anti-Asthmatic Agents | 2 | 2016 | 377 | 0.190 |
Why?
|
| Income | 2 | 2013 | 191 | 0.190 |
Why?
|
| Attitude of Health Personnel | 2 | 2008 | 1090 | 0.190 |
Why?
|
| Sickness Impact Profile | 3 | 2007 | 54 | 0.190 |
Why?
|
| Overweight | 2 | 2017 | 522 | 0.180 |
Why?
|
| Acquired Immunodeficiency Syndrome | 3 | 1992 | 226 | 0.180 |
Why?
|
| Medicine | 1 | 2023 | 118 | 0.180 |
Why?
|
| Chronic Disease | 4 | 2020 | 1715 | 0.180 |
Why?
|
| Administration, Oral | 3 | 2016 | 783 | 0.180 |
Why?
|
| Insurance Carriers | 1 | 2021 | 12 | 0.180 |
Why?
|
| Angiotensin Receptor Antagonists | 3 | 2017 | 94 | 0.180 |
Why?
|
| Drug Resistance | 2 | 2012 | 166 | 0.180 |
Why?
|
| Regression Analysis | 5 | 2016 | 987 | 0.170 |
Why?
|
| Sacrum | 3 | 1991 | 70 | 0.170 |
Why?
|
| Neonatology | 1 | 2020 | 22 | 0.170 |
Why?
|
| Guidelines as Topic | 2 | 2021 | 259 | 0.170 |
Why?
|
| Physician-Patient Relations | 3 | 2020 | 537 | 0.170 |
Why?
|
| Forecasting | 1 | 2021 | 363 | 0.160 |
Why?
|
| Risk Reduction Behavior | 1 | 2021 | 212 | 0.160 |
Why?
|
| Young Adult | 11 | 2021 | 12286 | 0.160 |
Why?
|
| Interviews as Topic | 5 | 2013 | 696 | 0.160 |
Why?
|
| Life Style | 3 | 2017 | 459 | 0.160 |
Why?
|
| Systole | 2 | 2017 | 190 | 0.160 |
Why?
|
| Cause of Death | 5 | 2018 | 392 | 0.160 |
Why?
|
| Medical Errors | 2 | 2012 | 104 | 0.160 |
Why?
|
| Education, Medical, Continuing | 2 | 2014 | 123 | 0.150 |
Why?
|
| Withholding Treatment | 2 | 2010 | 69 | 0.150 |
Why?
|
| Aspirin | 5 | 2014 | 379 | 0.150 |
Why?
|
| Doxycycline | 2 | 1996 | 57 | 0.150 |
Why?
|
| Cross Infection | 1 | 2020 | 203 | 0.150 |
Why?
|
| Disease Progression | 4 | 2015 | 2603 | 0.150 |
Why?
|
| Kidney Failure, Chronic | 1 | 2004 | 548 | 0.150 |
Why?
|
| Urban Population | 3 | 2014 | 436 | 0.150 |
Why?
|
| Liability, Legal | 1 | 2018 | 39 | 0.150 |
Why?
|
| Monitoring, Physiologic | 2 | 2013 | 265 | 0.150 |
Why?
|
| Acute Disease | 9 | 2008 | 978 | 0.150 |
Why?
|
| Disease Management | 2 | 2020 | 594 | 0.150 |
Why?
|
| Heart Rate | 3 | 2018 | 807 | 0.140 |
Why?
|
| Independent Living | 1 | 2018 | 96 | 0.140 |
Why?
|
| Cost Sharing | 1 | 1997 | 15 | 0.140 |
Why?
|
| Pediatric Obesity | 2 | 2016 | 568 | 0.140 |
Why?
|
| Censuses | 2 | 2014 | 27 | 0.140 |
Why?
|
| Hip Joint | 5 | 1991 | 159 | 0.140 |
Why?
|
| Longitudinal Studies | 8 | 2018 | 2668 | 0.140 |
Why?
|
| Tibia | 3 | 1999 | 183 | 0.140 |
Why?
|
| Pediatrics | 2 | 2015 | 1060 | 0.140 |
Why?
|
| Clinical Laboratory Techniques | 2 | 2009 | 86 | 0.140 |
Why?
|
| Patient Safety | 3 | 2020 | 292 | 0.130 |
Why?
|
| Health Services Misuse | 2 | 2020 | 36 | 0.130 |
Why?
|
| Diastole | 1 | 2017 | 151 | 0.130 |
Why?
|
| Atrial Fibrillation | 2 | 2013 | 370 | 0.130 |
Why?
|
| Tuberculosis, Spinal | 2 | 1995 | 7 | 0.130 |
Why?
|
| Exostoses, Multiple Hereditary | 1 | 1996 | 4 | 0.130 |
Why?
|
| Education, Medical, Graduate | 1 | 2020 | 436 | 0.130 |
Why?
|
| After-Hours Care | 2 | 2006 | 13 | 0.130 |
Why?
|
| Genital Diseases, Female | 1 | 1996 | 27 | 0.130 |
Why?
|
| Cysts | 1 | 1997 | 108 | 0.130 |
Why?
|
| Knee Joint | 2 | 1999 | 366 | 0.130 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2016 | 132 | 0.130 |
Why?
|
| Osteoma, Osteoid | 1 | 1995 | 4 | 0.120 |
Why?
|
| Humerus | 1 | 1995 | 41 | 0.120 |
Why?
|
| Femoral Neoplasms | 1 | 1995 | 10 | 0.120 |
Why?
|
| Prednisone | 1 | 2016 | 241 | 0.120 |
Why?
|
| Hospitals, Veterans | 3 | 2006 | 264 | 0.120 |
Why?
|
| Paraplegia | 1 | 1995 | 58 | 0.120 |
Why?
|
| Patient Care Team | 1 | 2020 | 605 | 0.120 |
Why?
|
| Thoracic Vertebrae | 1 | 1995 | 72 | 0.120 |
Why?
|
| Azithromycin | 1 | 1996 | 92 | 0.120 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 361 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 355 | 0.120 |
Why?
|
| Drug Interactions | 2 | 2007 | 370 | 0.120 |
Why?
|
| Intention to Treat Analysis | 1 | 2015 | 72 | 0.120 |
Why?
|
| Emergency Medical Service Communication Systems | 1 | 2014 | 6 | 0.120 |
Why?
|
| Selection Bias | 2 | 2005 | 37 | 0.120 |
Why?
|
| Poverty Areas | 1 | 2014 | 35 | 0.120 |
Why?
|
| Medical Records Systems, Computerized | 3 | 2010 | 91 | 0.120 |
Why?
|
| Recovery of Function | 2 | 2009 | 641 | 0.120 |
Why?
|
| Depression | 2 | 2014 | 1289 | 0.110 |
Why?
|
| Social Welfare | 1 | 2014 | 25 | 0.110 |
Why?
|
| Contraceptives, Oral | 1 | 2014 | 38 | 0.110 |
Why?
|
| Thinness | 1 | 2015 | 89 | 0.110 |
Why?
|
| Ambulatory Care Facilities | 2 | 2019 | 226 | 0.110 |
Why?
|
| Angiography | 1 | 2015 | 199 | 0.110 |
Why?
|
| Veterans | 5 | 2018 | 1397 | 0.110 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2014 | 79 | 0.110 |
Why?
|
| Sarcoma, Ewing | 1 | 1995 | 86 | 0.110 |
Why?
|
| Radiology | 2 | 2000 | 160 | 0.110 |
Why?
|
| Pharmacoepidemiology | 1 | 2014 | 21 | 0.110 |
Why?
|
| Emergency Treatment | 2 | 2007 | 116 | 0.110 |
Why?
|
| Diagnosis, Differential | 8 | 1998 | 1435 | 0.110 |
Why?
|
| Leg | 1 | 1996 | 241 | 0.110 |
Why?
|
| Pelvis | 2 | 1992 | 102 | 0.110 |
Why?
|
| Shoulder Joint | 3 | 1998 | 163 | 0.110 |
Why?
|
| Crowding | 2 | 2004 | 36 | 0.110 |
Why?
|
| Canada | 2 | 2007 | 355 | 0.110 |
Why?
|
| Kidney | 3 | 2016 | 1330 | 0.110 |
Why?
|
| Capitation Fee | 1 | 2013 | 14 | 0.110 |
Why?
|
| Transition to Adult Care | 1 | 2015 | 74 | 0.110 |
Why?
|
| Computer-Assisted Instruction | 2 | 1991 | 60 | 0.110 |
Why?
|
| Bone and Bones | 5 | 2000 | 297 | 0.110 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 657 | 0.110 |
Why?
|
| Creatinine | 2 | 2013 | 485 | 0.110 |
Why?
|
| Ossification, Heterotopic | 2 | 1993 | 17 | 0.110 |
Why?
|
| Potassium | 1 | 2013 | 140 | 0.110 |
Why?
|
| Administration, Inhalation | 1 | 2015 | 675 | 0.110 |
Why?
|
| Drug Therapy, Combination | 3 | 2011 | 1020 | 0.110 |
Why?
|
| Reimbursement, Incentive | 1 | 2013 | 36 | 0.110 |
Why?
|
| Pain | 4 | 1999 | 761 | 0.100 |
Why?
|
| Focus Groups | 3 | 2014 | 442 | 0.100 |
Why?
|
| Health Education | 3 | 2013 | 324 | 0.100 |
Why?
|
| Family Practice | 2 | 2015 | 451 | 0.100 |
Why?
|
| Digestive System Diseases | 1 | 2013 | 25 | 0.100 |
Why?
|
| Geography | 1 | 2013 | 185 | 0.100 |
Why?
|
| Confidence Intervals | 4 | 2010 | 318 | 0.100 |
Why?
|
| Models, Organizational | 2 | 2003 | 147 | 0.100 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2012 | 380 | 0.100 |
Why?
|
| Mycosis Fungoides | 1 | 1992 | 61 | 0.100 |
Why?
|
| Anthracyclines | 1 | 2012 | 46 | 0.100 |
Why?
|
| Cryptococcosis | 1 | 1992 | 26 | 0.100 |
Why?
|
| Delayed Diagnosis | 1 | 2012 | 81 | 0.100 |
Why?
|
| Surgical Wound Infection | 1 | 2015 | 291 | 0.100 |
Why?
|
| Time-to-Treatment | 1 | 2014 | 182 | 0.100 |
Why?
|
| Occupational Exposure | 2 | 2008 | 312 | 0.100 |
Why?
|
| Cardiotonic Agents | 1 | 2013 | 128 | 0.100 |
Why?
|
| Depressive Disorder | 2 | 2007 | 361 | 0.100 |
Why?
|
| Bone Diseases | 3 | 1991 | 60 | 0.100 |
Why?
|
| Pandemics | 1 | 2020 | 1516 | 0.100 |
Why?
|
| Health Care Surveys | 5 | 2013 | 560 | 0.090 |
Why?
|
| Vaccination | 2 | 2010 | 1350 | 0.090 |
Why?
|
| Inpatients | 2 | 2007 | 456 | 0.090 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 2 | 2008 | 102 | 0.090 |
Why?
|
| Abscess | 2 | 1992 | 73 | 0.090 |
Why?
|
| Lymphoma | 1 | 1992 | 190 | 0.090 |
Why?
|
| Drug Utilization | 3 | 2012 | 169 | 0.090 |
Why?
|
| Community-Institutional Relations | 1 | 2012 | 98 | 0.090 |
Why?
|
| Hospitals, Military | 1 | 2011 | 26 | 0.090 |
Why?
|
| Forms and Records Control | 1 | 2011 | 21 | 0.090 |
Why?
|
| Sex Distribution | 3 | 2011 | 357 | 0.090 |
Why?
|
| Attitude to Health | 1 | 2014 | 424 | 0.090 |
Why?
|
| Spondylitis, Ankylosing | 1 | 1992 | 45 | 0.090 |
Why?
|
| Breast Neoplasms | 2 | 2014 | 2112 | 0.090 |
Why?
|
| Sporotrichosis | 1 | 1991 | 4 | 0.090 |
Why?
|
| Coronary Care Units | 2 | 2007 | 16 | 0.090 |
Why?
|
| Musculoskeletal Diseases | 1 | 1992 | 69 | 0.090 |
Why?
|
| Patient Education as Topic | 2 | 2017 | 734 | 0.090 |
Why?
|
| Medical Laboratory Science | 1 | 2010 | 9 | 0.090 |
Why?
|
| United States Department of Veterans Affairs | 3 | 2011 | 637 | 0.090 |
Why?
|
| Patient-Centered Care | 2 | 2013 | 504 | 0.090 |
Why?
|
| Spinal Fractures | 1 | 1992 | 81 | 0.090 |
Why?
|
| Lung Diseases | 1 | 2017 | 755 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2019 | 3348 | 0.090 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2010 | 41 | 0.090 |
Why?
|
| Cervical Vertebrae | 1 | 1992 | 130 | 0.090 |
Why?
|
| Wrist | 1 | 1991 | 52 | 0.090 |
Why?
|
| Abdominal Neoplasms | 1 | 1990 | 32 | 0.090 |
Why?
|
| Racism | 1 | 2013 | 129 | 0.090 |
Why?
|
| Decision Making | 5 | 2016 | 837 | 0.090 |
Why?
|
| Parents | 3 | 2015 | 1301 | 0.090 |
Why?
|
| Cardiomyopathies | 1 | 2014 | 333 | 0.090 |
Why?
|
| Marfan Syndrome | 1 | 1990 | 42 | 0.090 |
Why?
|
| Physician Assistants | 2 | 2008 | 87 | 0.090 |
Why?
|
| Thoracic Neoplasms | 1 | 1990 | 34 | 0.090 |
Why?
|
| Muscles | 2 | 1988 | 322 | 0.090 |
Why?
|
| Preoperative Care | 1 | 1992 | 343 | 0.080 |
Why?
|
| Prescriptions | 1 | 2010 | 68 | 0.080 |
Why?
|
| Mummies | 1 | 1989 | 1 | 0.080 |
Why?
|
| Nurse Practitioners | 2 | 2008 | 126 | 0.080 |
Why?
|
| Physicians, Primary Care | 1 | 2013 | 233 | 0.080 |
Why?
|
| Washington | 2 | 2002 | 149 | 0.080 |
Why?
|
| Femur | 2 | 1992 | 242 | 0.080 |
Why?
|
| Bundle-Branch Block | 1 | 2009 | 30 | 0.080 |
Why?
|
| Severity of Illness Index | 5 | 2020 | 2767 | 0.080 |
Why?
|
| Wounds and Injuries | 2 | 2007 | 718 | 0.080 |
Why?
|
| Chickenpox Vaccine | 1 | 2010 | 71 | 0.080 |
Why?
|
| Community Health Services | 2 | 2008 | 224 | 0.080 |
Why?
|
| Pertussis Vaccine | 1 | 2009 | 21 | 0.080 |
Why?
|
| Parenting | 1 | 2013 | 291 | 0.080 |
Why?
|
| Pneumococcal Vaccines | 1 | 2010 | 140 | 0.080 |
Why?
|
| Algorithms | 2 | 2014 | 1626 | 0.080 |
Why?
|
| Medication Therapy Management | 1 | 2010 | 70 | 0.080 |
Why?
|
| Universities | 1 | 2012 | 404 | 0.080 |
Why?
|
| Whooping Cough | 1 | 2009 | 48 | 0.080 |
Why?
|
| Carcinoid Tumor | 1 | 1989 | 24 | 0.080 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2009 | 35 | 0.080 |
Why?
|
| Health Literacy | 1 | 2011 | 164 | 0.080 |
Why?
|
| Chickenpox | 1 | 2010 | 100 | 0.080 |
Why?
|
| Case-Control Studies | 5 | 2023 | 3334 | 0.080 |
Why?
|
| Shoulder Fractures | 1 | 1988 | 12 | 0.080 |
Why?
|
| Age of Onset | 1 | 2010 | 494 | 0.080 |
Why?
|
| Joints | 1 | 1989 | 97 | 0.080 |
Why?
|
| Exercise | 3 | 2009 | 1923 | 0.080 |
Why?
|
| Anemia | 1 | 2010 | 155 | 0.080 |
Why?
|
| Shoulder Injuries | 1 | 1988 | 56 | 0.080 |
Why?
|
| Health Surveys | 2 | 2009 | 485 | 0.070 |
Why?
|
| Patient Transfer | 2 | 2014 | 162 | 0.070 |
Why?
|
| Glomerular Filtration Rate | 4 | 2016 | 684 | 0.070 |
Why?
|
| Utilization Review | 2 | 2005 | 36 | 0.070 |
Why?
|
| Women's Health | 1 | 2011 | 361 | 0.070 |
Why?
|
| Probability | 4 | 2010 | 313 | 0.070 |
Why?
|
| Prosthesis Design | 4 | 2016 | 321 | 0.070 |
Why?
|
| Fibroma | 1 | 1988 | 23 | 0.070 |
Why?
|
| Medical History Taking | 1 | 2008 | 119 | 0.070 |
Why?
|
| X-Ray Film | 2 | 2000 | 5 | 0.070 |
Why?
|
| Insurance, Pharmaceutical Services | 1 | 2007 | 23 | 0.070 |
Why?
|
| Kidney Diseases | 1 | 2011 | 366 | 0.070 |
Why?
|
| Databases as Topic | 1 | 2007 | 65 | 0.070 |
Why?
|
| Diabetes Complications | 2 | 2006 | 227 | 0.070 |
Why?
|
| Health Policy | 2 | 2008 | 359 | 0.070 |
Why?
|
| Psychometrics | 3 | 2007 | 681 | 0.070 |
Why?
|
| Hemoglobins | 1 | 2010 | 343 | 0.070 |
Why?
|
| Arthralgia | 2 | 1998 | 52 | 0.070 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 2 | 2007 | 259 | 0.070 |
Why?
|
| Risk | 4 | 2014 | 866 | 0.070 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2012 | 750 | 0.070 |
Why?
|
| Radiographic Image Enhancement | 3 | 2000 | 58 | 0.070 |
Why?
|
| Diagnostic Errors | 2 | 2006 | 163 | 0.070 |
Why?
|
| Peak Expiratory Flow Rate | 1 | 2006 | 37 | 0.070 |
Why?
|
| Triage | 2 | 2006 | 211 | 0.070 |
Why?
|
| Thrombosis | 1 | 2010 | 331 | 0.070 |
Why?
|
| Joint Commission on Accreditation of Healthcare Organizations | 1 | 2006 | 8 | 0.070 |
Why?
|
| Analysis of Variance | 5 | 2007 | 1283 | 0.070 |
Why?
|
| Oregon | 1 | 2006 | 68 | 0.070 |
Why?
|
| Software | 2 | 1990 | 611 | 0.070 |
Why?
|
| Infant | 10 | 2010 | 8994 | 0.070 |
Why?
|
| Uterine Cervicitis | 1 | 2006 | 7 | 0.070 |
Why?
|
| Program Development | 1 | 2008 | 360 | 0.060 |
Why?
|
| Psychological Tests | 1 | 2007 | 133 | 0.060 |
Why?
|
| Hospitals, Special | 1 | 2006 | 9 | 0.060 |
Why?
|
| Violence | 1 | 2008 | 235 | 0.060 |
Why?
|
| Cardiac Care Facilities | 1 | 2006 | 13 | 0.060 |
Why?
|
| Cluster Analysis | 3 | 2014 | 479 | 0.060 |
Why?
|
| Patient Admission | 2 | 2004 | 185 | 0.060 |
Why?
|
| Lipids | 1 | 2009 | 614 | 0.060 |
Why?
|
| Office Visits | 3 | 2015 | 85 | 0.060 |
Why?
|
| Infant, Newborn | 6 | 2020 | 5704 | 0.060 |
Why?
|
| Biopsy | 4 | 1999 | 1093 | 0.060 |
Why?
|
| Chronology as Topic | 1 | 2005 | 2 | 0.060 |
Why?
|
| Anxiety | 1 | 2012 | 947 | 0.060 |
Why?
|
| Physicians, Family | 1 | 2007 | 208 | 0.060 |
Why?
|
| Antineoplastic Agents | 3 | 2014 | 2038 | 0.060 |
Why?
|
| Drug Therapy | 1 | 2005 | 77 | 0.060 |
Why?
|
| Computer Graphics | 3 | 1991 | 42 | 0.060 |
Why?
|
| Alcoholic Intoxication | 1 | 2006 | 63 | 0.060 |
Why?
|
| Sample Size | 1 | 2005 | 117 | 0.060 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2007 | 200 | 0.060 |
Why?
|
| Blood Glucose | 2 | 2018 | 2086 | 0.060 |
Why?
|
| Skin Neoplasms | 1 | 1992 | 828 | 0.060 |
Why?
|
| Angioplasty, Balloon | 1 | 2006 | 90 | 0.060 |
Why?
|
| Child Health Services | 1 | 2007 | 184 | 0.060 |
Why?
|
| Hospital-Physician Relations | 1 | 2024 | 3 | 0.060 |
Why?
|
| Pharmacokinetics | 1 | 2004 | 25 | 0.060 |
Why?
|
| Parent-Child Relations | 1 | 2007 | 252 | 0.060 |
Why?
|
| Mental Disorders | 1 | 2013 | 1024 | 0.060 |
Why?
|
| Computer Simulation | 2 | 1991 | 943 | 0.060 |
Why?
|
| Echocardiography | 2 | 2019 | 634 | 0.060 |
Why?
|
| Benchmarking | 1 | 2005 | 174 | 0.060 |
Why?
|
| Length of Stay | 2 | 2007 | 1126 | 0.060 |
Why?
|
| Hospital Bed Capacity | 1 | 2003 | 24 | 0.060 |
Why?
|
| Continuity of Patient Care | 1 | 2006 | 278 | 0.060 |
Why?
|
| Equipment Design | 2 | 2017 | 522 | 0.050 |
Why?
|
| Syndrome | 4 | 2006 | 342 | 0.050 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 3 | 1989 | 108 | 0.050 |
Why?
|
| Stents | 1 | 2007 | 518 | 0.050 |
Why?
|
| Melanoma | 1 | 1990 | 735 | 0.050 |
Why?
|
| Linear Models | 3 | 2011 | 817 | 0.050 |
Why?
|
| Cooperative Behavior | 2 | 2020 | 427 | 0.050 |
Why?
|
| Peer Review | 1 | 2003 | 46 | 0.050 |
Why?
|
| Hospitals, Pediatric | 1 | 2006 | 518 | 0.050 |
Why?
|
| Patient Care | 1 | 2023 | 109 | 0.050 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 2 | 2014 | 23 | 0.050 |
Why?
|
| Data Display | 2 | 1993 | 20 | 0.050 |
Why?
|
| Transportation of Patients | 1 | 2002 | 50 | 0.050 |
Why?
|
| Hirudins | 2 | 2014 | 51 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2012 | 1968 | 0.050 |
Why?
|
| Spinal Diseases | 3 | 1993 | 48 | 0.050 |
Why?
|
| Insurance Coverage | 2 | 2015 | 220 | 0.050 |
Why?
|
| Ankle Joint | 3 | 1993 | 172 | 0.050 |
Why?
|
| Cholesterol, HDL | 2 | 2014 | 203 | 0.050 |
Why?
|
| Bayes Theorem | 2 | 2014 | 367 | 0.050 |
Why?
|
| Neoplasms | 2 | 2013 | 2426 | 0.050 |
Why?
|
| Surgery Department, Hospital | 1 | 2000 | 22 | 0.040 |
Why?
|
| Pelvic Bones | 3 | 1995 | 151 | 0.040 |
Why?
|
| Mental Health | 2 | 2004 | 675 | 0.040 |
Why?
|
| Demography | 3 | 2007 | 280 | 0.040 |
Why?
|
| Italy | 1 | 2020 | 97 | 0.040 |
Why?
|
| Workplace | 1 | 2002 | 246 | 0.040 |
Why?
|
| Heparin | 2 | 2014 | 252 | 0.040 |
Why?
|
| Health Services for the Aged | 1 | 2001 | 72 | 0.040 |
Why?
|
| Alcoholism | 1 | 2007 | 759 | 0.040 |
Why?
|
| Lions | 1 | 1999 | 2 | 0.040 |
Why?
|
| Decision Support Techniques | 3 | 2009 | 387 | 0.040 |
Why?
|
| Triglycerides | 2 | 2014 | 519 | 0.040 |
Why?
|
| Medical Records | 3 | 2007 | 170 | 0.040 |
Why?
|
| Lung Neoplasms | 2 | 1990 | 2353 | 0.040 |
Why?
|
| Biomechanical Phenomena | 3 | 1993 | 784 | 0.040 |
Why?
|
| Pain Measurement | 2 | 2012 | 489 | 0.040 |
Why?
|
| Interdisciplinary Communication | 1 | 2020 | 189 | 0.040 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2019 | 78 | 0.040 |
Why?
|
| Diabetic Foot | 1 | 1999 | 23 | 0.040 |
Why?
|
| Reimbursement Mechanisms | 1 | 2019 | 83 | 0.040 |
Why?
|
| Sacroiliac Joint | 2 | 1991 | 35 | 0.040 |
Why?
|
| ST Elevation Myocardial Infarction | 1 | 2019 | 52 | 0.040 |
Why?
|
| Recombinant Proteins | 2 | 2014 | 1304 | 0.040 |
Why?
|
| Pain Management | 2 | 2012 | 319 | 0.040 |
Why?
|
| Rotation | 2 | 1996 | 118 | 0.040 |
Why?
|
| Fractures, Ununited | 2 | 1989 | 31 | 0.040 |
Why?
|
| Computed Tomography Angiography | 1 | 2019 | 115 | 0.040 |
Why?
|
| Neonatal Screening | 1 | 2000 | 161 | 0.040 |
Why?
|
| Peptide Fragments | 2 | 2014 | 694 | 0.040 |
Why?
|
| Acromion | 1 | 1997 | 7 | 0.040 |
Why?
|
| Stomach Neoplasms | 1 | 1999 | 97 | 0.040 |
Why?
|
| Positron-Emission Tomography | 1 | 2019 | 284 | 0.040 |
Why?
|
| Pilot Projects | 2 | 2014 | 1545 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2006 | 1206 | 0.040 |
Why?
|
| Occupational Health | 1 | 2020 | 195 | 0.040 |
Why?
|
| Pregnancy | 2 | 2007 | 6247 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 2011 | 1213 | 0.040 |
Why?
|
| Faculty, Medical | 1 | 2000 | 263 | 0.040 |
Why?
|
| Deductibles and Coinsurance | 1 | 1997 | 11 | 0.040 |
Why?
|
| Sensitivity and Specificity | 3 | 2000 | 1840 | 0.030 |
Why?
|
| Joint Diseases | 3 | 1999 | 59 | 0.030 |
Why?
|
| Qualitative Research | 2 | 2014 | 1192 | 0.030 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 1989 | 253 | 0.030 |
Why?
|
| Hip | 2 | 1988 | 54 | 0.030 |
Why?
|
| Non-ST Elevated Myocardial Infarction | 1 | 2016 | 18 | 0.030 |
Why?
|
| Postoperative Care | 2 | 2007 | 246 | 0.030 |
Why?
|
| Anemia, Sickle Cell | 1 | 2000 | 273 | 0.030 |
Why?
|
| Neuroectodermal Tumors, Primitive, Peripheral | 1 | 1995 | 2 | 0.030 |
Why?
|
| Accidents, Occupational | 1 | 1995 | 16 | 0.030 |
Why?
|
| Decision Trees | 1 | 1996 | 90 | 0.030 |
Why?
|
| Prosthesis Failure | 1 | 2016 | 120 | 0.030 |
Why?
|
| Urban Health | 1 | 1995 | 77 | 0.030 |
Why?
|
| Societies, Medical | 2 | 2010 | 760 | 0.030 |
Why?
|
| Health Services Accessibility | 3 | 2011 | 894 | 0.030 |
Why?
|
| Fracture Healing | 1 | 1995 | 78 | 0.030 |
Why?
|
| Government Programs | 1 | 2015 | 23 | 0.030 |
Why?
|
| Bladder Exstrophy | 1 | 1995 | 16 | 0.030 |
Why?
|
| Databases, Factual | 2 | 2008 | 1289 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 1995 | 211 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2015 | 163 | 0.030 |
Why?
|
| Echocardiography, Stress | 1 | 2014 | 21 | 0.030 |
Why?
|
| Clinical Coding | 1 | 2014 | 20 | 0.030 |
Why?
|
| Comparative Effectiveness Research | 1 | 2015 | 151 | 0.030 |
Why?
|
| ROC Curve | 3 | 2004 | 500 | 0.030 |
Why?
|
| Hip Dislocation, Congenital | 3 | 1991 | 37 | 0.030 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2014 | 29 | 0.030 |
Why?
|
| Occupational Diseases | 1 | 1995 | 142 | 0.030 |
Why?
|
| Propensity Score | 1 | 2015 | 262 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 1996 | 760 | 0.030 |
Why?
|
| Needs Assessment | 2 | 2008 | 360 | 0.030 |
Why?
|
| Communication Barriers | 1 | 2014 | 101 | 0.030 |
Why?
|
| Necrosis | 2 | 1992 | 234 | 0.030 |
Why?
|
| Early Medical Intervention | 1 | 2014 | 59 | 0.030 |
Why?
|
| Pleural Neoplasms | 1 | 1993 | 23 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2020 | 1020 | 0.030 |
Why?
|
| User-Computer Interface | 2 | 2010 | 147 | 0.030 |
Why?
|
| Lipoma | 1 | 1993 | 17 | 0.030 |
Why?
|
| History, Ancient | 1 | 2013 | 52 | 0.030 |
Why?
|
| Proteinuria | 1 | 2013 | 89 | 0.030 |
Why?
|
| Borrelia burgdorferi Group | 1 | 1992 | 8 | 0.030 |
Why?
|
| Hospitals, Community | 1 | 2013 | 50 | 0.030 |
Why?
|
| Erythema | 1 | 1992 | 28 | 0.030 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2013 | 105 | 0.030 |
Why?
|
| Bone Cysts | 1 | 1992 | 11 | 0.020 |
Why?
|
| Trastuzumab | 1 | 2012 | 97 | 0.020 |
Why?
|
| Drug Utilization Review | 1 | 2012 | 57 | 0.020 |
Why?
|
| Diuretics | 1 | 2012 | 74 | 0.020 |
Why?
|
| Cultural Competency | 1 | 2013 | 80 | 0.020 |
Why?
|
| Lymphedema | 1 | 1992 | 22 | 0.020 |
Why?
|
| Models, Structural | 2 | 1991 | 40 | 0.020 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2012 | 120 | 0.020 |
Why?
|
| Poverty | 1 | 1995 | 492 | 0.020 |
Why?
|
| Drug Costs | 1 | 2013 | 110 | 0.020 |
Why?
|
| Cellulitis | 1 | 1992 | 49 | 0.020 |
Why?
|
| Recurrence | 1 | 2015 | 1013 | 0.020 |
Why?
|
| Ohio | 1 | 2012 | 152 | 0.020 |
Why?
|
| Antibodies, Bacterial | 1 | 1992 | 137 | 0.020 |
Why?
|
| Body Weight | 1 | 2016 | 931 | 0.020 |
Why?
|
| Organizational Culture | 1 | 2012 | 138 | 0.020 |
Why?
|
| Physical Examination | 1 | 2013 | 237 | 0.020 |
Why?
|
| Radiology Information Systems | 1 | 1991 | 28 | 0.020 |
Why?
|
| Database Management Systems | 1 | 1991 | 47 | 0.020 |
Why?
|
| Hand Deformities, Congenital | 1 | 1991 | 8 | 0.020 |
Why?
|
| Sporothrix | 1 | 1991 | 3 | 0.020 |
Why?
|
| Heptavalent Pneumococcal Conjugate Vaccine | 1 | 2010 | 11 | 0.020 |
Why?
|
| Thoracic Diseases | 1 | 1991 | 13 | 0.020 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 1993 | 128 | 0.020 |
Why?
|
| Lung Diseases, Fungal | 1 | 1991 | 13 | 0.020 |
Why?
|
| Aspergillosis | 1 | 1991 | 22 | 0.020 |
Why?
|
| Awards and Prizes | 1 | 2012 | 65 | 0.020 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 1991 | 53 | 0.020 |
Why?
|
| Hand Injuries | 1 | 1991 | 35 | 0.020 |
Why?
|
| Hip Dislocation | 1 | 1991 | 48 | 0.020 |
Why?
|
| Wrist Joint | 1 | 1991 | 63 | 0.020 |
Why?
|
| Pyridines | 1 | 2014 | 472 | 0.020 |
Why?
|
| Anterior Cruciate Ligament Injuries | 1 | 1992 | 140 | 0.020 |
Why?
|
| Biomarkers | 1 | 2021 | 3874 | 0.020 |
Why?
|
| Referral and Consultation | 2 | 2006 | 727 | 0.020 |
Why?
|
| Splenic Diseases | 1 | 1990 | 5 | 0.020 |
Why?
|
| Tarsal Bones | 1 | 1990 | 33 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2013 | 473 | 0.020 |
Why?
|
| Calcinosis | 2 | 1990 | 255 | 0.020 |
Why?
|
| Fibula | 1 | 1990 | 46 | 0.020 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 1990 | 34 | 0.020 |
Why?
|
| Arthrography | 1 | 1989 | 17 | 0.020 |
Why?
|
| Hospitals, Urban | 1 | 1990 | 133 | 0.020 |
Why?
|
| Sternoclavicular Joint | 1 | 1989 | 9 | 0.020 |
Why?
|
| Occupations | 2 | 2002 | 42 | 0.020 |
Why?
|
| Osteoradionecrosis | 1 | 1989 | 2 | 0.020 |
Why?
|
| Pennsylvania | 1 | 2009 | 104 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 2013 | 308 | 0.020 |
Why?
|
| Urban Health Services | 1 | 2009 | 61 | 0.020 |
Why?
|
| Tibial Fractures | 1 | 1990 | 73 | 0.020 |
Why?
|
| Femoral Neck Fractures | 1 | 1989 | 22 | 0.020 |
Why?
|
| Rhabdomyosarcoma | 1 | 1990 | 63 | 0.020 |
Why?
|
| Foot Injuries | 1 | 1989 | 42 | 0.020 |
Why?
|
| Immunization, Secondary | 1 | 2009 | 88 | 0.020 |
Why?
|
| Social Class | 1 | 2011 | 256 | 0.020 |
Why?
|
| Security Measures | 1 | 2008 | 8 | 0.020 |
Why?
|
| Obstetrics | 1 | 2011 | 159 | 0.020 |
Why?
|
| Ankle | 1 | 1989 | 79 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2013 | 626 | 0.020 |
Why?
|
| Weapons | 1 | 2008 | 8 | 0.020 |
Why?
|
| Epiphyses, Slipped | 1 | 1988 | 4 | 0.020 |
Why?
|
| Emergency Nursing | 1 | 2008 | 19 | 0.020 |
Why?
|
| Observer Variation | 2 | 2000 | 321 | 0.020 |
Why?
|
| Femur Head | 1 | 1988 | 38 | 0.020 |
Why?
|
| Range of Motion, Articular | 1 | 1991 | 386 | 0.020 |
Why?
|
| Gynecology | 1 | 2011 | 174 | 0.020 |
Why?
|
| Orthopedic Equipment | 1 | 1988 | 5 | 0.020 |
Why?
|
| Foot | 1 | 1989 | 125 | 0.020 |
Why?
|
| Bacteroides Infections | 1 | 1988 | 2 | 0.020 |
Why?
|
| Shoulder | 1 | 1988 | 87 | 0.020 |
Why?
|
| Neoplasms, Unknown Primary | 1 | 1988 | 12 | 0.020 |
Why?
|
| Radiation Injuries | 1 | 1989 | 139 | 0.020 |
Why?
|
| Poisson Distribution | 1 | 2008 | 75 | 0.020 |
Why?
|
| Ilium | 1 | 1988 | 29 | 0.020 |
Why?
|
| Methods | 1 | 1987 | 63 | 0.020 |
Why?
|
| Educational Status | 1 | 1990 | 458 | 0.020 |
Why?
|
| Musculoskeletal System | 1 | 1988 | 46 | 0.020 |
Why?
|
| Myositis | 1 | 1987 | 49 | 0.020 |
Why?
|
| Hip Fractures | 1 | 1988 | 82 | 0.020 |
Why?
|
| Carcinoma | 1 | 1989 | 214 | 0.020 |
Why?
|
| Nomograms | 1 | 2007 | 48 | 0.020 |
Why?
|
| Personnel Turnover | 1 | 2007 | 37 | 0.020 |
Why?
|
| Statistics, Nonparametric | 2 | 2001 | 424 | 0.020 |
Why?
|
| Suburban Population | 1 | 2007 | 16 | 0.020 |
Why?
|
| Escherichia coli Infections | 1 | 1988 | 105 | 0.020 |
Why?
|
| Midwifery | 1 | 2008 | 47 | 0.020 |
Why?
|
| Metals | 1 | 1988 | 126 | 0.020 |
Why?
|
| Orthopedics | 1 | 1989 | 141 | 0.020 |
Why?
|
| Interview, Psychological | 1 | 2007 | 88 | 0.020 |
Why?
|
| Liver Diseases | 1 | 1990 | 284 | 0.020 |
Why?
|
| Prostheses and Implants | 1 | 1988 | 140 | 0.020 |
Why?
|
| Diagnosis-Related Groups | 1 | 2006 | 28 | 0.020 |
Why?
|
| Neuroblastoma | 1 | 1988 | 152 | 0.020 |
Why?
|
| Reperfusion | 1 | 2006 | 37 | 0.020 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2006 | 80 | 0.020 |
Why?
|
| Disclosure | 1 | 2007 | 109 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 1993 | 895 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 1987 | 159 | 0.020 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 1989 | 233 | 0.020 |
Why?
|
| Wound Healing | 1 | 1989 | 308 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2007 | 238 | 0.020 |
Why?
|
| Appointments and Schedules | 1 | 2006 | 81 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 1993 | 995 | 0.020 |
Why?
|
| Skin | 1 | 1991 | 737 | 0.020 |
Why?
|
| Bacterial Infections | 1 | 1987 | 236 | 0.020 |
Why?
|
| Research | 1 | 2008 | 413 | 0.020 |
Why?
|
| Reference Values | 1 | 2007 | 791 | 0.020 |
Why?
|
| Physical Endurance | 1 | 2006 | 267 | 0.020 |
Why?
|
| Insurance, Hospitalization | 1 | 2004 | 4 | 0.010 |
Why?
|
| Refusal to Participate | 1 | 2004 | 6 | 0.010 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2006 | 106 | 0.010 |
Why?
|
| Safety | 1 | 2006 | 325 | 0.010 |
Why?
|
| Palliative Care | 1 | 1990 | 712 | 0.010 |
Why?
|
| Nurses | 1 | 2006 | 163 | 0.010 |
Why?
|
| Operations Research | 1 | 2003 | 2 | 0.010 |
Why?
|
| Bed Occupancy | 1 | 2003 | 13 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 1570 | 0.010 |
Why?
|
| Animals | 3 | 1999 | 34628 | 0.010 |
Why?
|
| Total Quality Management | 1 | 2003 | 61 | 0.010 |
Why?
|
| Hyperlipidemias | 1 | 2004 | 124 | 0.010 |
Why?
|
| Health Planning | 1 | 2003 | 48 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2007 | 859 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2004 | 319 | 0.010 |
Why?
|
| Ambulances | 1 | 2002 | 49 | 0.010 |
Why?
|
| Efficiency, Organizational | 1 | 2003 | 131 | 0.010 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2006 | 334 | 0.010 |
Why?
|
| Microcomputers | 2 | 1991 | 16 | 0.010 |
Why?
|
| Disability Evaluation | 1 | 2003 | 290 | 0.010 |
Why?
|
| Teleradiology | 1 | 2000 | 5 | 0.010 |
Why?
|
| Group Processes | 1 | 2001 | 55 | 0.010 |
Why?
|
| Radiography, Abdominal | 1 | 2000 | 40 | 0.010 |
Why?
|
| Communication | 1 | 2006 | 839 | 0.010 |
Why?
|
| Aspergillus niger | 1 | 1999 | 9 | 0.010 |
Why?
|
| Animals, Zoo | 1 | 1999 | 12 | 0.010 |
Why?
|
| Area Under Curve | 1 | 2000 | 285 | 0.010 |
Why?
|
| Video Recording | 1 | 2000 | 161 | 0.010 |
Why?
|
| Radiography, Thoracic | 1 | 2000 | 162 | 0.010 |
Why?
|
| Technetium | 1 | 1999 | 11 | 0.010 |
Why?
|
| Ventilation | 1 | 1999 | 40 | 0.010 |
Why?
|
| Markov Chains | 1 | 2000 | 124 | 0.010 |
Why?
|
| Gangrene | 1 | 1999 | 10 | 0.010 |
Why?
|
| Air Microbiology | 1 | 1999 | 41 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1999 | 126 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 2 | 1989 | 175 | 0.010 |
Why?
|
| Chondroma | 1 | 1998 | 1 | 0.010 |
Why?
|
| Activities of Daily Living | 1 | 2001 | 382 | 0.010 |
Why?
|
| Immunoglobulin E | 1 | 1999 | 353 | 0.010 |
Why?
|
| Rotator Cuff | 1 | 1997 | 44 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1999 | 822 | 0.010 |
Why?
|
| Femur Head Necrosis | 2 | 1988 | 8 | 0.010 |
Why?
|
| Smoking | 1 | 2004 | 1501 | 0.010 |
Why?
|
| Sick Leave | 1 | 1995 | 15 | 0.010 |
Why?
|
| Philadelphia | 1 | 1995 | 44 | 0.010 |
Why?
|
| Workers' Compensation | 1 | 1995 | 27 | 0.010 |
Why?
|
| Pelvimetry | 1 | 1995 | 2 | 0.010 |
Why?
|
| Epispadias | 1 | 1995 | 4 | 0.010 |
Why?
|
| Industry | 1 | 1995 | 64 | 0.010 |
Why?
|
| Cloaca | 1 | 1995 | 49 | 0.010 |
Why?
|
| Employment | 1 | 1995 | 161 | 0.010 |
Why?
|
| Patient Care Planning | 1 | 1995 | 152 | 0.010 |
Why?
|
| Computer Terminals | 1 | 1993 | 5 | 0.010 |
Why?
|
| Cost of Illness | 1 | 1995 | 290 | 0.010 |
Why?
|
| Osteotomy | 1 | 1995 | 164 | 0.010 |
Why?
|
| Rupture | 1 | 1992 | 101 | 0.010 |
Why?
|
| Radiotherapy, Computer-Assisted | 1 | 1991 | 12 | 0.010 |
Why?
|
| Casts, Surgical | 1 | 1992 | 32 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 1991 | 65 | 0.010 |
Why?
|
| Anterior Cruciate Ligament | 1 | 1992 | 82 | 0.010 |
Why?
|
| Bone Marrow | 1 | 1993 | 262 | 0.010 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 1990 | 3 | 0.010 |
Why?
|
| Traction | 1 | 1991 | 19 | 0.010 |
Why?
|
| Knee Injuries | 1 | 1992 | 98 | 0.010 |
Why?
|
| Cardiac Tamponade | 1 | 1990 | 15 | 0.010 |
Why?
|
| Spinal Cord Compression | 1 | 1990 | 19 | 0.010 |
Why?
|
| Hypercalcemia | 1 | 1990 | 21 | 0.010 |
Why?
|
| Femoral Fractures | 1 | 1991 | 74 | 0.010 |
Why?
|
| Antiemetics | 1 | 1990 | 38 | 0.010 |
Why?
|
| Narcotics | 1 | 1990 | 47 | 0.010 |
Why?
|
| Nausea | 1 | 1990 | 104 | 0.010 |
Why?
|
| Back | 1 | 1990 | 11 | 0.010 |
Why?
|
| Pneumocystis | 1 | 1990 | 11 | 0.010 |
Why?
|
| Neutropenia | 1 | 1990 | 135 | 0.010 |
Why?
|
| Nerve Block | 1 | 1990 | 69 | 0.010 |
Why?
|
| Ischium | 1 | 1989 | 5 | 0.010 |
Why?
|
| Sternum | 1 | 1989 | 25 | 0.010 |
Why?
|
| Analgesics | 1 | 1990 | 165 | 0.010 |
Why?
|
| Spinal Neoplasms | 1 | 1989 | 29 | 0.010 |
Why?
|
| Fever | 1 | 1990 | 301 | 0.000 |
Why?
|
| Clavicle | 1 | 1989 | 33 | 0.000 |
Why?
|
| Adipose Tissue | 1 | 1993 | 588 | 0.000 |
Why?
|
| Fracture Fixation | 1 | 1989 | 82 | 0.000 |
Why?
|
| Enterobacter | 1 | 1987 | 7 | 0.000 |
Why?
|
| Thigh | 1 | 1987 | 53 | 0.000 |
Why?
|
| Neoplasm Invasiveness | 1 | 1989 | 479 | 0.000 |
Why?
|
| Accidents, Traffic | 1 | 1989 | 188 | 0.000 |
Why?
|
| Enterobacteriaceae Infections | 1 | 1987 | 37 | 0.000 |
Why?
|
| Lung | 1 | 1999 | 3925 | 0.000 |
Why?
|
| Social Support | 1 | 1990 | 581 | 0.000 |
Why?
|
| Reoperation | 1 | 1989 | 555 | 0.000 |
Why?
|
| Ultrasonography | 1 | 1990 | 727 | 0.000 |
Why?
|
| Streptococcal Infections | 1 | 1987 | 145 | 0.000 |
Why?
|
| Models, Biological | 1 | 1991 | 1702 | 0.000 |
Why?
|
| Osteoarthritis | 1 | 1986 | 179 | 0.000 |
Why?
|
| Staphylococcal Infections | 1 | 1987 | 385 | 0.000 |
Why?
|
| Brain | 1 | 1991 | 2592 | 0.000 |
Why?
|